Views & Analysis Live Well: when health and opportunity knocks Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International.
News GSK could split amid pressure from investors - report GlaxoSmithKline’s chairman, Philip Hampton, may be considering splitting the company amid pressure from top investors to separate the company into consumer, pharma and vaccines divisions.
News GSK's blockbuster HIV drug linked with birth defects Regulators issue warning after preliminary study findings
Events Partner Content Rational Combinations 360 Addressing key aspects across all facets of combination
News Mixed results from Roche's key new drugs in Q1 Lacklustre performance from GSK as results season begins
News Genentech buys Regor's next-gen CDK inhibitors for $850M Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.